[시장보고서]hERG 스크리닝 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2034년)

hERG 스크리닝 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2034년)

hERG Screening Market (Type: Gene KCNH2 and Mutant KCNH2; and Ion Channel: Voltage-Gated and Ligand-Gated) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

상품코드 : 1531074

리서치사 : Transparency Market Research

발행일 : 2024년 06월

페이지 정보 : 영문 144 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,795

￦ 8,671,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,795

￦ 13,159,000

PDF (Multi-user License)

PDF 보고서를 동일 부서 5명이 이용할 수 있는 라이선스입니다. 텍스트 등의 Copy & Paste가 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 11,795

￦ 17,648,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

샘플 요청 목록에 추가

hERG 스크리닝 시장 - 조사 범위

TMR의 조사 보고서 "hERG 스크리닝 세계 시장"은 2024년부터 2034년까지의 예측 기간 동안 시장 지표에 대한 귀중한 인사이트를 얻기 위해 과거뿐만 아니라 현재의 성장 동향과 기회를 조사합니다. 이 보고서는 2024년을 기준 연도, 2034년을 예측 연도로 하여 2018년부터 2034년까지 세계 hERG 스크리닝 시장의 수익과 예측을 제공합니다. 또한 2024년부터 2034년까지 세계 hERG 스크리닝 시장의 연평균 성장률(CAGR %)도 제시합니다.

이 보고서는 광범위한 조사를 통해 작성되었습니다. 1차 조사에서 애널리스트는 주요 오피니언 리더, 업계 리더, 오피니언 메이커를 대상으로 인터뷰를 진행했습니다. 2차 조사에서는 주요 기업의 제품 자료, 연례 보고서, 보도자료, 관련 자료 등을 참고하여 hERG 스크리닝 시장을 추론했습니다.

시장 스냅샷
2023년 시장 금액	22억 달러
2034년 시장 금액	82억 달러
CAGR	12.6%

이 보고서는 세계 hERG 스크리닝 시장의 경쟁 환경을 조사하고 있습니다. 세계 hERG 스크리닝 시장에서 활동하는 주요 업체들이 확인되었으며, 각 업체는 다양한 속성별로 프로파일링되어 있습니다. 회사 개요, 재무 상태, 최근 동향, SWOT 등은 세계 hERG 스크리닝 시장 기업의 속성 중 일부로 이 보고서에서 다룹니다.

시장 기업 - 경쟁 매트릭스(기업 계층과 규모별)
시장 점유율 분석 : 기업별(2023년)
기업 개요
- Abcam Limited
- ABR-Affinity BioReagents, Inc.
- AstraZeneca plc
- Aureus Sciences
- AVIVA Biosciences
- Cambridge Biosciences
- ChanTest Corporation
- Charles River Laboratories
- Chemaxon

ksm

영문 목차

영문목차

hERG Screening Market - Scope of Report

TMR's report on the global hERG screening market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global hERG screening market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global hERG screening market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the hERG screening market.

Market Snapshot
Market Value in 2023	US$ 2.2 Bn
Market Value in 2034	US$ 8.2 Bn
CAGR	12.6%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global hERG screening market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global hERG screening market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global hERG screening market.

The report delves into the competitive landscape of the global hERG screening market. Key players operating in the global hERG screening market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global hERG screening market profiled in this report.

Key Questions Answered in Global hERG screening Market Report:

What is the sales/revenue generated by hERG screening across all regions during the forecast period?
What are the opportunities in the global hERG screening market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2034?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?

hERG Screening Market - Research Objectives and Research Approach

The comprehensive report on the global hERG screening market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global hERG screening market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global hERG screening market.

1. Preface

1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: hERG Screening Market

4. Market Overview

4.1. Introduction
- 4.1.1. Product Definition
- 4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
4.4. HERG Screening Market Analysis and Forecast, 2020-2034

5. Key Insights

5.1. Pipeline Analysis
5.2. Key Product /Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry

6. Global hERG Screening Market Analysis and Forecast, by Type

6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Type, 2020-2034
- 6.3.1. Gene KCNH2
- 6.3.2. Mutant KCNH2
6.4. Market Attractiveness Analysis, by Type

7. Global hERG Screening Market Analysis and Forecast, by Ion Channel

7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Ion Channel, 2020-2034
- 7.3.1. Voltage-Gated
- 7.3.2. Ligand-Gated
7.4. Market Attractiveness Analysis, by Ion Channel

8. Global hERG Screening Market Analysis and Forecast, by Application

8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Application, 2020-2034
- 8.3.1. Antiarrhythmic
- 8.3.2. Antipsychotic
- 8.3.3. Antibiotics
- 8.3.4. Others
8.4. Market Attractiveness Analysis, by Application

9. Global hERG Screening Market Analysis and Forecast, by Region

9.1. Key Findings
9.2. Market Value Forecast, by Region, 2020-2034
- 9.2.1. North America
- 9.2.2. Europe
- 9.2.3. Asia Pacific
- 9.2.4. Latin America
- 9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region

10. North America hERG Screening Market Analysis and Forecast

10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Type, 2020-2034
- 10.3.1. Gene KCNH2
- 10.3.2. Mutant KCNH2
10.4. Market Value Forecast, by Ion Channel, 2020-2034
- 10.4.1. Voltage-Gated
- 10.4.2. Ligand-Gated
10.5. Market Value Forecast, by Application, 2020-2034
- 10.5.1. Antiarrhythmic
- 10.5.2. Antipsychotic
- 10.5.3. Antibiotics
- 10.5.4. Others
10.6. Market Value Forecast, by Country, 2020-2034
- 10.6.1. U.S.
- 10.6.2. Canada
10.7. Market Attractiveness Analysis
- 10.7.1. By Type
- 10.7.2. By Ion Channel
- 10.7.3. By Application
- 10.7.4. By Country

11. Europe hERG Screening Market Analysis and Forecast

11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Type, 2020-2034
- 11.3.1. Gene KCNH2
- 11.3.2. Mutant KCNH2
11.4. Market Value Forecast, by Ion Channel, 2020-2034
- 11.4.1. Voltage-Gated
- 11.4.2. Ligand-Gated
11.5. Market Value Forecast, by Application, 2020-2034
- 11.5.1. Antiarrhythmic
- 11.5.2. Antipsychotic
- 11.5.3. Antibiotics
- 11.5.4. Others
11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
- 11.6.1. Germany
- 11.6.2. U.K.
- 11.6.3. France
- 11.6.4. Italy
- 11.6.5. Spain
- 11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
- 11.7.1. By Type
- 11.7.2. By Ion Channel
- 11.7.3. By Application
- 11.7.4. By Country/Sub-region

12. Asia Pacific hERG Screening Market Analysis and Forecast

12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Type, 2020-2034
- 12.3.1. Gene KCNH2
- 12.3.2. Mutant KCNH2
12.4. Market Value Forecast, by Ion Channel, 2020-2034
- 12.4.1. Voltage-Gated
- 12.4.2. Ligand-Gated
12.5. Market Value Forecast, by Application, 2020-2034
- 12.5.1. Antiarrhythmic
- 12.5.2. Antipsychotic
- 12.5.3. Antibiotics
- 12.5.4. Others
12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
- 12.6.1. China
- 12.6.2. Japan
- 12.6.3. India
- 12.6.4. Australia & New Zealand
- 12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
- 12.7.1. By Type
- 12.7.2. By Ion Channel
- 12.7.3. By Application
- 12.7.4. By Country/Sub-region

13. Latin America hERG Screening Market Analysis and Forecast

13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Type, 2020-2034
- 13.3.1. Gene KCNH2
- 13.3.2. Mutant KCNH2
13.4. Market Value Forecast, by Ion Channel, 2020-2034
- 13.4.1. Voltage-Gated
- 13.4.2. Ligand-Gated
13.5. Market Value Forecast, by Application, 2020-2034
- 13.5.1. Antiarrhythmic
- 13.5.2. Antipsychotic
- 13.5.3. Antibiotics
- 13.5.4. Others
13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
- 13.6.1. Brazil
- 13.6.2. Mexico
- 13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
- 13.7.1. By Type
- 13.7.2. By Ion Channel
- 13.7.3. By Application
- 13.7.4. By Country/Sub-region

14. Middle East & Africa hERG Screening Market Analysis and Forecast

14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Type, 2020-2034
- 14.3.1. Gene KCNH2
- 14.3.2. Mutant KCNH2
14.4. Market Value Forecast, by Ion Channel, 2020-2034
- 14.4.1. Voltage-Gated
- 14.4.2. Ligand-Gated
14.5. Market Value Forecast, by Application, 2020-2034
- 14.5.1. Antiarrhythmic
- 14.5.2. Antipsychotic
- 14.5.3. Antibiotics
- 14.5.4. Others
14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
- 14.6.1. GCC Countries
- 14.6.2. South Africa
- 14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
- 14.7.1. By Type
- 14.7.2. By Ion Channel
- 14.7.3. By Application
- 14.7.4. By Country/Sub-region

15. Competition Landscape

15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2023)
15.3. Company Profiles
- 15.3.1. Abcam Limited
  - 15.3.1.1. Company Overview
  - 15.3.1.2. Product Portfolio
  - 15.3.1.3. SWOT Analysis
  - 15.3.1.4. Financial Overview
  - 15.3.1.5. Strategic Overview
- 15.3.2. ABR-Affinity BioReagents, Inc.
  - 15.3.2.1. Company Overview
  - 15.3.2.2. Product Portfolio
  - 15.3.2.3. SWOT Analysis
  - 15.3.2.4. Financial Overview
  - 15.3.2.5. Strategic Overview
- 15.3.3. AstraZeneca plc
  - 15.3.3.1. Company Overview
  - 15.3.3.2. Product Portfolio
  - 15.3.3.3. SWOT Analysis
  - 15.3.3.4. Financial Overview
  - 15.3.3.5. Strategic Overview
- 15.3.4. Aureus Sciences
  - 15.3.4.1. Company Overview
  - 15.3.4.2. Product Portfolio
  - 15.3.4.3. SWOT Analysis
  - 15.3.4.4. Financial Overview
  - 15.3.4.5. Strategic Overview
- 15.3.5. AVIVA Biosciences
  - 15.3.5.1. Company Overview
  - 15.3.5.2. Product Portfolio
  - 15.3.5.3. SWOT Analysis
  - 15.3.5.4. Financial Overview
  - 15.3.5.5. Strategic Overview
- 15.3.6. Cambridge Biosciences
  - 15.3.6.1. Company Overview
  - 15.3.6.2. Product Portfolio
  - 15.3.6.3. SWOT Analysis
  - 15.3.6.4. Financial Overview
  - 15.3.6.5. Strategic Overview
- 15.3.7. ChanTest Corporation
  - 15.3.7.1. Company Overview
  - 15.3.7.2. Product Portfolio
  - 15.3.7.3. SWOT Analysis
  - 15.3.7.4. Financial Overview
  - 15.3.7.5. Strategic Overview
- 15.3.8. Charles River Laboratories
  - 15.3.8.1. Company Overview
  - 15.3.8.2. Product Portfolio
  - 15.3.8.3. SWOT Analysis
  - 15.3.8.4. Financial Overview
  - 15.3.8.5. Strategic Overview
- 15.3.9. Chemaxon
  - 15.3.9.1. Company Overview
  - 15.3.9.2. Product Portfolio
  - 15.3.9.3. SWOT Analysis
  - 15.3.9.4. Financial Overview
  - 15.3.9.5. Strategic Overview

한글목차

hERG 스크리닝 시장 - 조사 범위

목차

제1장 서문

제2장 가정과 조사 방법

제3장 주요 요약 : 시장

제4장 시장 개요

제5장 주요 인사이트

제6장 세계의 시장 분석과 예측 : 유형별

제7장 세계의 시장 분석과 예측 : 이온 채널별

제8장 세계의 시장 분석과 예측 : 용도별

제9장 세계의 시장 분석과 예측 : 지역별

제10장 북미의 시장 분석과 예측

제11장 유럽의 시장 분석과 예측

제12장 아시아태평양의 시장 분석과 예측

제13장 라틴아메리카의 시장 분석과 예측

제14장 중동 및 아프리카의 시장 분석과 예측

제15장 경쟁 상황